Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2008: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Research Abstract |
Gene therapy using hammerhead ribozyme were studied. It is known that hammerhead ribozyme can only cleave RNAs with UC or UA or UU sequence near the cleavage site. Based on the crystal structure of the hammerhead ribozyme, we drastically expanded the variations of the cleavable sequences, in a logical and rational manner (base-substitutions or a non-standard base-introduction into the hammerhead ribozyme). These modified ribozymes with wider cleavable sequences could be useful for a gene therapy.
|